Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration symbols : Ltrn save search
Lantern Pharma Leverages AI Platform, RADR®, to Develop Breakthrough Antibody Drug Conjugates (ADCs) in Collaboration with Bielefeld University
Published: 2023-06-08 (Crawled : 16:00) - biospace.com/
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 2.23%
H: 2.56%
C: 1.67%
radr pharma drug antibody collaboration
Lantern Pharma and TTC Oncology Establish AI Collaboration to Expand the Clinical Development of Drug Candidate TTC-352
Published: 2023-02-27 (Crawled : 14:00) - biospace.com/
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 0.19%
H: 2.5%
C: 1.73%
ttc-352 pharma drug candidate collaboration
Lantern Pharma Expands into Additional Pediatric Cancers Through a Collaboration with The Greehey Children's Cancer Research Institute (GCCRI) at University of Texas Health Science Center-San Antonio
Published: 2022-02-15 (Crawled : 13:00) - biospace.com/
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 1.39%
H: 3.65%
C: 3.65%
health research collaboration cancer children
Lantern Pharma Announces Collaboration & Research Agreement with The Danish Cancer Society Research Center to Support Clinical Development of Drug Candidates, LP-100 and LP-184, in Solid Tumors
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 2.48%
H: 0.0%
C: -11.41%
lp-100 solid tumors ces announces collaboration drug research 100 collaboration cancer
Lantern Pharma's Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®, Surpasses 10 Billion Datapoints - Significantly Enhancing Precision Medicine Capabilities & Expanding Potential for Biopharma Collaborations and Partnerships
Published: 2021-11-01 (Crawled : 13:00) - prnewswire.com
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: -2.6%
partnership biopharma potential collaboration drug platform
Code Ocean Selected by Lantern Pharma to Power A.I. and Computational Biology Research & Data-Driven Oncology Drug Development Collaborations
Published: 2021-10-27 (Crawled : 14:15) - biospace.com/
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: -0.18%
H: 0.37%
C: -6.98%
collaboration computational drug research
Code Ocean Selected by Lantern Pharma to Power A.I. and Computational Biology Research & Data-Driven Oncology Drug Development Collaborations
Published: 2021-10-27 (Crawled : 13:00) - prnewswire.com
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: -0.18%
H: 0.37%
C: -6.98%
collaboration computational drug research
Lantern Pharma Enters into Strategic Collaboration with Deep Lens -- Partnership Expected to Accelerate Enrollment in Upcoming Phase 2 Clinical Trial for Never-Smokers with Non-Small Cell Lung Cancer
Published: 2021-09-28 (Crawled : 14:00) - biospace.com/
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 2.8%
H: 0.34%
C: -10.23%
partnership phase 2 lung cancer collaboration cancer trial enroll
Lantern Pharma Announces Positive Preclinical Data in Glioblastoma (GBM) with Drug Candidate LP-184 and Expands GBM Research Collaboration
Published: 2021-08-19 (Crawled : 13:00) - prnewswire.com
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: -2.4%
H: 0.0%
C: -3.07%
positive collaboration drug research preclinical pre-clinical glioblastoma
Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform
Published: 2021-05-03 (Crawled : 12:15) - biospace.com/
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 1.87%
H: 6.08%
C: 4.51%
artificial intelligence collaboration research pharma
Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®, Surpasses 4.6 Billion Datapoints, Accelerating the Company’s Progress in the Development of Biopharma Collaborations and Partnerships and Advancing the Company’s Strategy to Develop the World’s Largest A.I. Platform for Oncology-Focused Drug Development & Rescue
Published: 2021-04-29 (Crawled : 14:00) - lanternpharma.com
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 0.63%
H: 0.31%
C: -1.19%
partnership biopharma collaboration drug
Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma
Published: 2020-12-17 (Crawled : 15:00) - biospace.com/
LTRN | News | $5.75 -0.35% 48K
|
Health Technology
|
| O: 0.0%
H: 10.2%
C: 8.49%
brain cancer cancer collaboration therapy announces collaboration train glioblastoma
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.14 57.0% 59M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.